Handelsbanken Fonder’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,100
| Closed | -$154K | – | 1560 |
|
|
2025
Q1 | $154K | Hold |
23,100
| – | – | ﹤0.01% | 1504 |
|
|
2024
Q4 | $290K | Buy |
23,100
+4,900
| +27% | +$61.5K | ﹤0.01% | 1459 |
|
|
2024
Q3 | $336K | Hold |
18,200
| – | – | ﹤0.01% | 1384 |
|
|
2024
Q2 | $392K | Buy |
18,200
+600
| +3% | +$12.9K | ﹤0.01% | 1271 |
|
|
2024
Q1 | $474K | Hold |
17,600
| – | – | ﹤0.01% | 1187 |
|
|
2023
Q4 | $527K | Buy |
17,600
+5,300
| +43% | +$159K | ﹤0.01% | 1122 |
|
|
2023
Q3 | $252K | Hold |
12,300
| – | – | ﹤0.01% | 1373 |
|
|
2023
Q2 | $244K | Buy |
+12,300
| New | +$244K | ﹤0.01% | 1432 |
|
|
2022
Q1 | – | Sell |
-9,600
| Closed | -$210K | – | 1724 |
|
|
2021
Q4 | $210K | Hold |
9,600
| – | – | ﹤0.01% | 1695 |
|
|
2021
Q3 | $287K | Hold |
9,600
| – | – | ﹤0.01% | 1600 |
|
|
2021
Q2 | $425K | Buy |
9,600
+4,000
| +71% | +$177K | ﹤0.01% | 1492 |
|
|
2021
Q1 | $248K | Buy |
+5,600
| New | +$248K | ﹤0.01% | 1495 |
|